4Capucci A,Villani GQ,Aschieri D,et al. Safety of oral propafenone in the eonversion of recent onset alrial fibrillation to sinus rhythm : a prospective parallel placebo - controlled multicentre study[J]. Int J Cardiol, 1999,68(2) :187- 196
3Waldo AL, Prystowsky EN, Drug treattnent of atrial fibrillation in the managed care era. Am J C ardiol, 1998,12,8 (5A) :23 c-29c.
4Huang DT, Monaham KM,Zimetbaum P, et al. Hybrid pharam cologic and ablative therapy: a novel and effective approach for the management of atrial fibrillation. J Cardiovasc Electrophysiol, 1998,9 ( 5 ) :462-462.
5Braunward主编,心脏病学(第5版).北京:人民卫生出版社,2000.556-556.
6Borituti G,Aleatandro C. Tiziano L,et al. Propafenone for conversion of recent- enset atrial fibrillation: a controlled comparison between oral loading close and intravenous administration, Cheat, 1995,108 ( 2 ):355-358.
7Capucci A, Villani GQ, Aschieri D, et al. Safety of oral propafenone in the conversion of recent onset atrial fibrillation to sinus rhythm: a prospective parallel placebo - controlled multicentre study. Int J Cardiol,1999,68(2) :187-196.
8Capucci A, Boriani G, Rubino G, et al. A controlled study on oral propafenone versus digoxin plus quinidine in converting recent onset atrial fibrillation to sinus rhym. Int J Caridiol,1994,43(5) :305.
2Patel AA,White CM,Shah SA,et al.The relationship between statin use and atrial fibrillation[J].Curr Med Res Opin,2007,23(5):1177-1185.
3Chung MK,Martin DO,Sprecher D,et al.C reactive protein elevation in patients with atrial arrhythmias:inflammatory mechanisms and persistence of atrial fibrillatio[J].Circulation,2001,104(24):2886-2891.
4Dernellis J,Panaretou M.Relationship between creactive protein concentrations during glucocorticoid therapy and recurrent atrial fibrillation[J].Eur Heart J,2004,25(19):1100-1107.
